In situ demonstration of Epstein-Barr virus small RNAs (EBERI) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site.
Detection of hepatitis C virus infection with recombinant immunoblot assay, synthetic immunoblot assay, and polymerase chain reaction
β Scribed by R. K. Chaudhary; A. Andonov; C. Maclean
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 313 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0887-8013
No coin nor oath required. For personal study only.
β¦ Synopsis
The newly developed immunoblot assay, RlBA SIA (recombinant and synthetic polypeptide immunoblot assay), Chiron, Calif., was compared with the commercially available second generation recombinant immunoblot assay (RIBA-2) for the detection of antibody to hepatitis C virus (anti-HCV). The two immunoblot tests were also compared with the polymerase chain reaction (PCR) for the detection of HCV RNA.
Ninety-one percent of samples reactive by RIBA-2 were positive for anti-HCV by RlBA SIA. A total of 31 % of RIBA-2 indeterminate samples became reactive by RlBA SIA, 24% became non-reactive, and 45% remained the same.
Samples reactive by RIBA-2 or SIA from different risk groups, were mostly positive (67-1 00%) by PCR for HCV RNA. All indeterminate samples from hemophiliacs and intravenous drug users were PCR positive. RlBA SIA is more sensitive and specific than RIBA-2 and correlates well with PCR results C D 1993 Wiley-Liss. Inc.
π SIMILAR VOLUMES
## Abstract Fiftyβseven sera with indeterminate results by the second generation RIBA (RIBA 2) for confirmation of hepatitis C virus (HCV) enzyme linked immunoassay (ELISA) reactivity were tested by the new third generation RIBA (RIBA 3). Thirty three (57.9%) displayed reactivity for at least one o
GB Virus C/Hepatitis G Virus (GBV-C/HGV) was identified recently and only two assays, consisting of a single recombinant protein, have been described for determination of the seroprevalence of this virus. An immunoblot assay was devised, which contains four recombinant GBV-C/HGV proteins. In this st
## Abstract Hepatitis C virus is one of the main causes of chronic hepatitis in developing countries. The current study was to evaluate the efficacy of the enzymeβlinked immunosorbent assay third generation (ELISAβ3) for detection of antibodies to hepatitis C virus (antiβHCV) in comparison with rev
The combination of reverse transcription and polymerase chain reaction is a very powerful tool for the detection of hepatitis C virus RNA in sera of patients with hepatitis C virus infection. However, when studying the presence of this virus in tissue using polymerase chain reaction, it may be diffi